Thursday, October 28, 2021

I Definitely Want to Go to a Hospital Whose Ownership Has “a Steadfast Commitment to Diversity, Inclusion and Equity” or DIE for Short

By Merlin
Thu, Oct 28, 2021 11:04 a.m.

I definitely want to go to a hospital whose ownership has "a steadfast commitment to diversity, inclusion and equity" or DIE for short.

'I definitely want to go to a hospital whose ownership has "a steadfast commitment to diversity, inclusion and equity" or DIE for short.'-- Bob Byrd (just kidding, really--I meant to say Steve Sailer)


eahilf said...

So Steve 'muh Constitution' Sailer has taken a break from whining about ghetto Blacks blasting each other into the grave to opine about the Duvall/Novant Health case.

One article I saw about this verdict contained the following:

"Duvall was a strong advocate of diversity at Novant," Largess (ed: one of Duvall's lawyers) said.

LOL -- yeah, no one loves 'diversity' more than me, just as long as it's not my job that's given to a non-white (or in this case a woman) -- but the truth is, hiring is generally zero sum, meaning for every non-white hired to satisfy 'diversity' goals, a White is not hired; that's the reality -- apparently this is OK with Duvall and his lawyer.

Saying you're 'a strong advocate for diversity' is as contemptible as a white person prefacing some remark involving race by saying I'm not a racist, but ...


Anonymous said...

YEP. I bet some lefty thought up that DIE and got a real rush of it. How smart he was! Sure.

Anonymous said...


GRA:It may not help you,but you'll feel real good about things while they give you all the other crap(remdesivir),which they drop into patient's mouths or IVs to kill them in the hospital.

(AP) — A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.

Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.

They’ve shared the results with the U.S. National Institutes of Health, which publishes treatment guidelines, and they hope for a World Health Organization recommendation.

“If WHO recommends this, you will see it widely taken up,” said study co-author Dr. Edward Mills of McMaster University in Hamilton, Ontario, adding that many poor nations have the drug readily available. “We hope it will lead to a lot of lives saved.”

The pill, called fluvoxamine, would cost $4 for a course of COVID-19 treatment. By comparison, antibody IV treatments cost about $2,000 and Merck’s experimental antiviral pill for COVID-19 is about $700 per course. Some experts predict various treatments eventually will be used in combination to fight the coronavirus.

Researchers tested the antidepressant in nearly 1,500 Brazilians recently infected with coronavirus who were at risk of severe illness because of other health problems, such as diabetes. About half took the antidepressant at home for 10 days, the rest got dummy pills. They were tracked for four weeks to see who landed in the hospital or spent extended time in an emergency room when hospitals were full.

In the group that took the drug, 11% needed hospitalization or an extended ER stay, compared to 16% of those on dummy pills.

GRA:I guess it's SOMETHING--not a cure though.